Aquinox Pharmaceuticals, Inc.

San Bruno,  CA 
United States
  • Booth: 2149, 2726

Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on chronic urological conditions marked by inflammation and pain. Our product candidates target SHIP1, an enzyme that serves to down-regulate inflammation through its role in the PI3K signaling pathway. Aquinox’s lead drug candidate is being studied in interstitial cystitis/bladder pain syndrome.